Skip to Main Content

Current Funding Opportunities

Click here to visit the NCI grant site.

Use your device's search function to find a specific disease or funding source.


Funding

The Vera and Joseph Dresner Foundation MDS Research Fund
The fund will facilitate the advancement of innovative basic science, translational or clinical research to advance the understanding and treatment of Myelodysplastic Syndromes (MDS) and related blood disorders (such as MDS/myeloproliferative neoplasms (MPN) overlap syndromes, secondary acute myeloid leukemia following MDS, idiopathic cytopenia of undetermined significance (ICUS), or clonal hematopoiesis of indeterminate potential (CHIP).

The foundation will consider proposals from individuals at university, college, hospital, or laboratory institutions for support of research in MDS or related disorders in two types:
- Early Career Awards
- Established Investigator Awards

Letter of Intent (LOI) Deadline: LOIs are accepted on a rolling basis.
Learn More>>

Fast Funding for COVID-19 Science

If you are a scientist at an academic institution currently working on a COVID-19 related project and in need of funding, we invite you to apply for a Fast Grant.

Deadline: Fast Grant decisions are made in under 48 hours. Apply Now!

Apply for a Fast Funding grant now>>


Department of Defense Lung Cancer Research Program

The FY20 Defense Appropriations Act provides funding to the Department of Defense Lung Cancer Research Program (LCRP) to support innovative, high-impact lung cancer research. Pre-application and application deadlines will be available when the Program Announcements are released.

Learn more about the DoD Lung Award>>


AACR Breast Cancer Research Fellowships

This joint effort is to encourage and support postdoctoral or clinical research fellows to conduct breast cancer research and to establish a successful career path in this field.

Application Deadline: January 18, 2021


NCCN Request for Proposals (RFP): Phase I/II Clinical and Correlative/Preclinical Trials of Decitabine and Cedazuridine for Hematologic Malignancies and Solid Tumors

This RFP, made possible by a research grant from Taiho Oncology, Inc., is to support NCCN Member Institution faculty for the performance of clinical and correlative studies of decitabine and cedazuridine (DEC-C) in the treatment of hematologic malignancies and solid tumors.

Application Deadline: January 19, 2021


Cancer Intervention and Surveillance Modeling Network (CISNET) Incubator Program for New Cancer Sites (U01)

The overarching goal of this FOA is to expand comparative simulation modeling approaches developed by CISNET to new cancer organ sites beyond the sites which have been previously funded (breast, colorectal, prostate, lung, esophageal, and cervical) under CISNET.

Application Deadline: January 20, 2021
Cancer Research Education Grants Program

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of the NCI R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation’s biomedical, behavioral and clinical research needs.
Due Dates: January 25, 2021

AACR Cancer Disparities Research Fellowships

This effort is to encourage and support postdoctoral or clinical research fellows to conduct cancer disparities research and to establish a successful career path in this field.

Application Deadline: January 27, 2021



AACR Lung Cancer Research Fellowships

This joint effort is to encourage and support postdoctoral or clinical research fellows to conduct lung cancer research and to establish a successful career path in this field.

Application Deadline: January 29, 2021


New Cohorts for Environmental Exposures and Cancer Risk (CEECR) (UG3/UH3/U24)

Through this FOA, the NCI and NIEHS invite applications to support innovative scientific research in new prospective cohorts that addresses knowledge gaps in cancer etiology and carcinogenesis processes with a focus on environmental exposures.
Application Deadline: January 29, 2021
Utilizing In Vitro Functional Genomics Advances for Gene-Environment (G x E) Discovery and Validation (R01)

The purpose of this FOA is to solicit applications that fully integrate recent innovative advances of in vitro functional genomics tools/technologies and approaches for environmental health and toxicology research. The overall goal of this NIEHS led initiative is to generate proof-of-principle studies incorporating these new in vitro approaches, together with well characterized exposures, to further our understanding of gene-environment (G x E) interactions in complex human disorders.

Application Deadline: February 1, 2021


Lustgarten Foundation-AACR Career Development Award for Pancreatic Cancer Research, in honor of Ruth Bader Ginsburg

This award is to honor the life and legacy of Justice Ginsburg, who worked tirelessly to advance gender equality, even while battling pancreatic cancer. The intent of this program is to support the development and diversity of talent working in pancreatic cancer research.

Application Deadline: February 4, 2021



Lustgarten Foundation-AACR Career Development Award for Pancreatic Cancer Research, in Honor of John Robert Lewis

This award is to honor the life and legacy of Representative Lewis, who worked tirelessly to advance the civil rights of all Americans, even while battling pancreatic cancer. The intent of this program is to support the development and diversity of talent working in pancreatic cancer research.

Application Deadline: February 4, 2021


Chance for Life - Pediatric Cancer Initiatives

This opportunity funds research that drives new, innovative treatments for Pediatric Cancers especially in the area of pediatric neuro-oncology.

Letter of Intent Due: February 5, 2021
Clinical Translation of Activated Optical Fluorescence Methods and Technologies for Sensitive Cancer Detection in Vivo (R01)

The purpose of this FOA is to bring a highly sensitive imaging technology capable of detecting very small (1-3 mm3) tumors in vivo to clinical utility.

Application Deadline: February 10, 2021

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3)

Through these FOAs, the NCI invites applications to support the validation of molecular/cellular/imaging markers and assays for cancer detection, diagnosis, prognosis, monitoring, and prediction of response or resistance to treatment, as well as markers for cancer prevention and control.

Application Deadline: February 18, 2021


Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21)

This FOA solicits grant applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies offering novel molecular or cellular analysis capabilities for basic or clinical cancer research.

Application Deadline: February 22, 2021



Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33)

This FOA invites grant applications proposing exploratory research projects focused on further development and validation of emerging technologies offering novel capabilities for targeting, probing, or assessing molecular and cellular features of cancer biology for basic or clinical cancer research.

Application Deadline: February 22, 2021


Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21)

This FOA solicits grant applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies that improve the quality of the samples used for cancer research or clinical care.

Application Deadline: February 22, 2021


Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33)

This FOA solicits grant applications proposing exploratory research projects focused on further development and validation of emerging technologies that improve the quality of the samples used for cancer research or clinical care.
Application Deadline: February 22, 2021


AACR Clinical Oncology Research (CORE) Training Fellowships

Designed to provide an effective industry-academic clinical practicum with a unique training opportunity to develop academic clinicians in drug development.

Application Deadline: February 28, 2021


Social and Behavioral Intervention Research to Address Modifiable Risk Factors for Cancer in Rural Populations (R01)

The purpose of this FOA is to solicit applications to develop, adapt, and test individual-, community- or multilevel interventions to address modifiable risk factors for cancer in rural populations.

Application Deadline: March 15, 2021

Learn more about the rural population award>>

The Mark Foundation Endeavor Awards

These grants are awarded to teams of three or more investigators to generate and integrate data from diverse lines of research and transform those insights into advances for cancer patients that could not be achieved by individual efforts.

Application Deadline: March 1, 2021
International Research Scientist Development Award (IRSDA) (K01)

The purpose of this Award is to provide support and protected time (three to five years) to advanced postdoctoral U.S. research scientists and recently-appointed U.S. junior faculty for an intensive, mentored research career development experience in a low- or middle-income country leading to an independently-funded research career focused on global health.
Application Deadline: March 9, 2021



Department of Defense (DoD) Breast Cancer Awards

Cancer Grand Challenges Program

The NCI and Cancer Research UK (CRUK) are partnering to fund the Cancer Grand Challenges program. Cancer Grand Challenges will fund novel ideas by multidisciplinary research teams from around the world that offer the potential to advance bold cancer research and improve outcomes for people affected by cancer. These nine challenges are aimed at solving complex problems in cancer research, which, if solved, could have a transformative impact towards progress.

Application Deadline: April 22, 2021


The Cure Starts Now Foundation Research Grants

Research questions considered - Disease Impact: Does the study propose an intervention or clinical tool that will reduce the morbidity or mortality from or potentially find a cure for pediatric brain cancer? Innovation: Does the research study propose a novel approach or represent advancement in current treatment of pediatric brain cancer?

Application Deadline: June 1, 2021



Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program

The BMSF DCTCDP is a 2-year program designed to support the career development of early-stage investigator (as defined by NIH) physicians underrepresented in medicine, or physicians who have a demonstrated commitment to increasing diversity in clinical research, to become independent clinical trial investigators who are engaged in advancing health equity through their research and mentoring.

Application Deadline: July 2, 2021